Symbiosis has a proven track record of delivering aseptic manufacturing projects across a range of modalities:
• Vaccines
Supporting clinical batches across traditional attenuated or inactivated products to recombinant, viral vector and nucleic acid-based vaccine technologies
• Small Molecules
Symbiosis has provided GMP manufacturing across a wide range of small molecule applications, including highly potent materials requiring specialist handling
• Antibody-Drug Conjugates
Overcome your development and manufacturing challenges with a partner that has the experience and capabilities to handle your highly potent ADC
• RNA and Peptide Therapies
Often have challenging manufacturing and handling requirements that need specialist knowledge and experience
• mAbs and Recombinant Proteins
Extensive experience in delivering hundreds of biological drug projects allowing us to support your clinical trials
• Advanced Therapy Medicinal Product (ATMP) and Viral Vector Therapies
Clinical and small-scale commercial manufacturing of advanced therapeutics such as viral vectors for cell and gene therapies and raw materials such as plasmids